Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient’s satisfaction with therapy: The CINDERELLA trial

Background Breast cancer therapy improved significantly, allowing for different surgical approaches for the same disease stage, therefore offering patients different aesthetic outcomes with similar locoregional control. The purpose of the CINDERELLA trial is to evaluate an artificial-intelligence (AI) cloud-based platform (CINDERELLA platform) vs the standard approach for patient education prior to therapy. Methods A prospective randomized international multicentre trial comparing two methods for patient education prior to therapy. After institutional ethics approval and a written informed consent, patients planned for locoregional treatment will be randomized to the intervention (CINDERELLA platform) or controls. The patients in the intervention arm will use the newly designed web-application (CINDERELLA platform, CINDERELLA APProach) to access the information related to surgery and/or radiotherapy. Using an AI system, the platform will provide the patient with a picture of her own aesthetic outcome resulting from the surgical procedure she chooses, and an objective evaluation of this aesthetic outcome (e.g., good/fair). The control group will have access to the standard approach. The primary objectives of the trial will be i) to examine the differences between the treatment arms with regards to patients’ pre-treatment expectations and the final aesthetic outcomes and ii) in the experimental arm only, the agreement of the pre-treatment AI-evaluation (output) and patient’s post-therapy self-evaluation. Discussion The project aims to develop an easy-to-use cost-effective AI-powered tool that improves shared decision-making processes. We assume that the CINDERELLA APProach will lead to higher satisfaction, better psychosocial status, and wellbeing of breast cancer patients, and reduce the need for additional surgeries to improve aesthetic outcome.

[1]  A. Zubarevich,et al.  Present and future of machine learning in breast surgery: systematic review , 2022, The British journal of surgery.

[2]  O. Damman,et al.  Cocreation with Dutch patients of decision‐relevant information to support shared decision‐making about adjuvant treatment in breast cancer care , 2022, Health expectations : an international journal of public participation in health care and health policy.

[3]  M. Meregaglia,et al.  An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. , 2021, Social science & medicine.

[4]  V. Tjan-Heijnen,et al.  Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy , 2021, Breast Cancer.

[5]  E. Rutgers,et al.  Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Hui Liu,et al.  Global, regional, and national mortality trends of female breast cancer by risk factor, 1990–2017 , 2021, BMC Cancer.

[7]  T. Kühn,et al.  A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges , 2021, Breast.

[8]  Y. Charalabidis Artificial Intelligence (AI) , 2020, Industry, Innovation and Infrastructure.

[9]  G. Pozzi,et al.  Artificial intelligence (AI) in breast cancer care - Leveraging multidisciplinary skills to improve care☆ , 2020, Breast.

[10]  A. Holton,et al.  Breast Cancer Prevention and Treatment: Misinformation on Pinterest, 2018. , 2020, American journal of public health.

[11]  V. McCormack,et al.  Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. , 2020, The Lancet. Global health.

[12]  R. Rainsbury,et al.  Oncoplastic breast-conserving surgery for women with primary breast cancer , 2020 .

[13]  Jaime S. Cardoso,et al.  Evolution, current challenges, and future possibilities in the objective assessment of aesthetic outcome of breast cancer locoregional treatment , 2019, Breast.

[14]  K. Slim,et al.  From informed consent to shared decision-making in surgery. , 2019, Journal of visceral surgery.

[15]  Isaac S Kohane,et al.  Artificial Intelligence in Healthcare , 2019, Artificial Intelligence and Machine Learning for Business for Non-Engineers.

[16]  D. Noh,et al.  Effect of cosmetic outcome on quality of life after breast cancer surgery. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  M. Golatta,et al.  Predictors of early poor aesthetic outcome after breast‐conserving surgery in patients with breast cancer: Initial results of a prospective cohort study at a single institution , 2014, Journal of surgical oncology.

[18]  M. Cardoso,et al.  Assessing cosmetic results after breast conserving surgery , 2014, Journal of surgical oncology.

[19]  Gladys McPherson,et al.  Methods of Randomization , 2010 .

[20]  Murray Leaf,et al.  WHAT IS “FORMAL” ANALYSIS? , 2004, Cybern. Syst..

[21]  M. Salah,et al.  Methodology , 2003 .

[22]  A. A. Afifi,et al.  Sample size determinations for the two rater kappa statistic , 1988 .

[23]  S. Pocock,et al.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.

[24]  R. Neal PROJECT ADMINISTRATION , 2009 .